Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hematopoietic Stem Cell Transplantation From Haploidentical Donors in Patients With Hematological Malignancies Using a Treosulfan-Based Preparative Regimen

NCT04195633 is registered in ClinicalTrials.gov with Fred Hutchinson Cancer Center as lead sponsor.

NCT NCT04195633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04195633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hematopoietic Stem Cell Transplantation From Haploidentical Donors in Patients With Hematological Malignancies Using a Treosulfan-Based Preparative Regimen
Lead sponsor
Fred Hutchinson Cancer Center
Phase
Phase 2
Overall status
Recruiting
Start date
January 25, 2021
Completion date
March 12, 2029
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute leukemia, acute lymphoblastic leukemia, acute myeloid leukemia, adult diffuse large cell lymphoma, anaplastic large cell lymphoma, burkitt lymphoma, chronic myeloid leukemia, bcr-abl1 positive, chronic myelomonocytic leukemia, hodgkin lymphoma, lymphoblastic lymphoma, lymphoplasmacytic lymphoma, mantle cell lymphoma, mixed phenotype acute leukemia, myelodysplastic syndrome, prolymphocytic leukemia, refractory chronic lymphocytic leukemia, refractory follicular lymphoma, refractory marginal zone lymphoma, refractory small lymphocytic lymphoma